MARK KLEINER: Open Payments
NPI 1982610184 · FOREST, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,758 in 73 payments from 22 companies in 2025. Trend: 2023 $2,487 · 2024 $2,103 · 2025 $1,758
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $339 |
| AstraZeneca Pharmaceuticals LP | 2 | $217 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $211 |
| Abbott Laboratories | 7 | $160 |
| PFIZER INC. | 13 | $140 |
| ABBVIE INC. | 4 | $92 |
| Kowa Pharmaceuticals America, Inc. | 1 | $88 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Insmed, Inc. | 2 | $59 |
| Amgen Inc. | 3 | $47 |
Products named: JARDIANCE, Ozempic, FREESTYLE LIBRE 3, LOKELMA, FARXIGA, Wegovy, ZORYVE, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
